These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
780 related articles for article (PubMed ID: 15192040)
1. Stimulation of insulin-like growth factor (IGF) binding protein-3 synthesis by IGF-I and transforming growth factor-alpha is mediated by both phosphatidylinositol-3 kinase and mitogen-activated protein kinase pathways in mammary epithelial cells. Sivaprasad U; Fleming J; Verma PS; Hogan KA; Desury G; Cohick WS Endocrinology; 2004 Sep; 145(9):4213-21. PubMed ID: 15192040 [TBL] [Abstract][Full Text] [Related]
2. The mitogen-activated protein kinase pathway tonically inhibits both basal and IGF-I-stimulated IGF-binding protein-5 production in mammary epithelial cells. Fleming JM; Brandimarto JA; Cohick WS J Endocrinol; 2007 Aug; 194(2):349-59. PubMed ID: 17641284 [TBL] [Abstract][Full Text] [Related]
3. Insulin-like growth factor I-mediated protection from rapamycin-induced apoptosis is independent of Ras-Erk1-Erk2 and phosphatidylinositol 3'-kinase-Akt signaling pathways. Thimmaiah KN; Easton J; Huang S; Veverka KA; Germain GS; Harwood FC; Houghton PJ Cancer Res; 2003 Jan; 63(2):364-74. PubMed ID: 12543789 [TBL] [Abstract][Full Text] [Related]
4. Differential regulation of the phosphoinositide 3-kinase and MAP kinase pathways by hepatocyte growth factor vs. insulin-like growth factor-I in myogenic cells. Halevy O; Cantley LC Exp Cell Res; 2004 Jul; 297(1):224-34. PubMed ID: 15194438 [TBL] [Abstract][Full Text] [Related]
5. Insulin-like growth factor (IGF) binding protein-3 potentiation of IGF action is mediated through the phosphatidylinositol-3-kinase pathway and is associated with alteration in protein kinase B/AKT sensitivity. Conover CA; Bale LK; Durham SK; Powell DR Endocrinology; 2000 Sep; 141(9):3098-103. PubMed ID: 10965879 [TBL] [Abstract][Full Text] [Related]
6. Insulin-like growth factor-I-dependent signal transduction pathways leading to the induction of cell growth and differentiation of human neuroblastoma cell line SH-SY5Y: the roles of MAP kinase pathway and PI 3-kinase pathway. Kurihara S; Hakuno F; Takahashi S Endocr J; 2000 Dec; 47(6):739-51. PubMed ID: 11228049 [TBL] [Abstract][Full Text] [Related]
7. Roles of phosphatidylinositol 3-kinase and mitogen-activated protein kinase pathways in stimulation of vascular smooth muscle cell migration and deoxyriboncleic acid synthesis by insulin-like growth factor-I. Imai Y; Clemmons DR Endocrinology; 1999 Sep; 140(9):4228-35. PubMed ID: 10465296 [TBL] [Abstract][Full Text] [Related]
8. Insulin-like growth factor-I inhibits cell growth in the a549 non-small lung cancer cell line. Kodama Y; Baxter RC; Martin JL Am J Respir Cell Mol Biol; 2002 Sep; 27(3):336-44. PubMed ID: 12204896 [TBL] [Abstract][Full Text] [Related]
9. Constitutive expression of IGF-binding protein-3 by mammary epithelial cells alters signaling through Akt and p70S6 kinase. Grill CJ; Sivaprasad U; Cohick WS J Mol Endocrinol; 2002 Aug; 29(1):153-62. PubMed ID: 12200236 [TBL] [Abstract][Full Text] [Related]
10. Activation of IRS-2-mediated signal transduction by IGF-1, but not TGF-alpha or EGF, augments pancreatic beta-cell proliferation. Lingohr MK; Dickson LM; McCuaig JF; Hugl SR; Twardzik DR; Rhodes CJ Diabetes; 2002 Apr; 51(4):966-76. PubMed ID: 11916914 [TBL] [Abstract][Full Text] [Related]
11. Insulin-like growth factor-1 regulates endogenous RUNX2 activity in endothelial cells through a phosphatidylinositol 3-kinase/ERK-dependent and Akt-independent signaling pathway. Qiao M; Shapiro P; Kumar R; Passaniti A J Biol Chem; 2004 Oct; 279(41):42709-18. PubMed ID: 15304489 [TBL] [Abstract][Full Text] [Related]
12. The role of mitogen-activated protein kinase in insulin and insulin-like growth factor I (IGF-I) signaling cascades for progesterone and IGF-binding protein-1 production in human granulosa cells. Seto-Young D; Zajac J; Liu HC; Rosenwaks Z; Poretsky L J Clin Endocrinol Metab; 2003 Jul; 88(7):3385-91. PubMed ID: 12843192 [TBL] [Abstract][Full Text] [Related]
13. Anchorage-independent activation of mitogen-activated protein kinase through phosphatidylinositol-3 kinase by insulin-like growth factor I. Suzuki K; Takahashi K Biochem Biophys Res Commun; 2000 May; 272(1):111-5. PubMed ID: 10872812 [TBL] [Abstract][Full Text] [Related]
15. Insulin-like growth factor (IGF)-I stimulates cell proliferation and induces IGF binding protein (IGFBP)-3 and IGFBP-5 gene expression in cultured growth plate chondrocytes via distinct signaling pathways. Kiepe D; Ciarmatori S; Hoeflich A; Wolf E; Tönshoff B Endocrinology; 2005 Jul; 146(7):3096-104. PubMed ID: 15845624 [TBL] [Abstract][Full Text] [Related]
16. Inhibition of insulin-like growth factor signaling pathways in mammary gland by pure antiestrogen ICI 182,780. Chan TW; Pollak M; Huynh H Clin Cancer Res; 2001 Aug; 7(8):2545-54. PubMed ID: 11489838 [TBL] [Abstract][Full Text] [Related]
17. Endogenous IGFBP-3 is required for both growth factor-stimulated cell proliferation and cytokine-induced apoptosis in mammary epithelial cells. Leibowitz BJ; Cohick WS J Cell Physiol; 2009 Jul; 220(1):182-8. PubMed ID: 19259947 [TBL] [Abstract][Full Text] [Related]
18. Somatostatin inhibits hepatic growth hormone receptor and insulin-like growth factor I mRNA expression by activating the ERK and PI3K signaling pathways. Hagemeister AL; Sheridan MA Am J Physiol Regul Integr Comp Physiol; 2008 Aug; 295(2):R490-7. PubMed ID: 18495839 [TBL] [Abstract][Full Text] [Related]
19. Activation of phosphatidylinositol 3-kinase contributes to insulin-like growth factor I-mediated inhibition of pancreatic beta-cell death. Liu W; Chin-Chance C; Lee EJ; Lowe WL Endocrinology; 2002 Oct; 143(10):3802-12. PubMed ID: 12239091 [TBL] [Abstract][Full Text] [Related]